Title: Pharmacologic characterization of novel adenosine A2A receptor agonists in equine neutrophils.
Journal: American journal of veterinary research 20070901
Title: Characterization of the potency, selectivity, and pharmacokinetic profile for six adenosine A2A receptor antagonists.
Journal: Naunyn-Schmiedeberg's archives of pharmacology 20070401
Title: Characterization of adenosine receptors in the human bladder carcinoma T24 cell line.
Journal: European journal of pharmacology 20060424
Title: Generation of adenosine A3 receptor functionally humanized mice for the evaluation of the human antagonists.
Journal: Biochemical pharmacology 20060112
Title: 2-(Benzimidazol-2-yl)quinoxalines: a novel class of selective antagonists at human A(1) and A(3) adenosine receptors designed by 3D database searching.
Journal: Journal of medicinal chemistry 20051229
Title: Human adenosine A(3) receptor leads to intracellular Ca(2+) mobilization but is insufficient to activate the signaling pathway via phosphoinositide 3-kinase gamma in mice.
Journal: Biochemical pharmacology 20051115
Title: Synthesis and structure-activity relationships of 4-cycloalkylamino-1, 2, 4-triazolo[4, 3-a]quinoxalin-1- one derivatives as A1 and A3 adenosine receptor antagonists.
Journal: Archiv der Pharmazie 20040101
Title: A3 adenosine receptor agonist IB-MECA reduces myocardial ischemia-reperfusion injury in dogs.
Journal: American journal of physiology. Heart and circulatory physiology 20030801
Title: Differential allosteric modulation by amiloride analogues of agonist and antagonist binding at A(1) and A(3) adenosine receptors.
Journal: Biochemical pharmacology 20030215
Title: Pharmacological analysis of calcium responses mediated by the human A3 adenosine receptor in monocyte-derived dendritic cells and recombinant cells.
Journal: Molecular pharmacology 20030201
Title: Gene dosage-dependent effects of cardiac-specific overexpression of the A3 adenosine receptor.
Journal: Circulation research 20020726
Title: Selective allosteric enhancement of agonist binding and function at human A3 adenosine receptors by a series of imidazoquinoline derivatives.
Journal: Molecular pharmacology 20020701
Title: Sustained ER Ca2+ depletion suppresses protein synthesis and induces activation-enhanced cell death in mast cells.
Journal: The Journal of biological chemistry 20020419
Title: Allosteric modulation of A(3) adenosine receptors by a series of 3-(2-pyridinyl)isoquinoline derivatives.
Journal: Molecular pharmacology 20011101
Title: [(3)H]MRE 3008F20: a novel antagonist radioligand for the pharmacological and biochemical characterization of human A(3) adenosine receptors.
Journal: Molecular pharmacology 20000501
Title: Structure-activity relationships and molecular modeling of 3, 5-diacyl-2,4-dialkylpyridine derivatives as selective A3 adenosine receptor antagonists.
Journal: Journal of medicinal chemistry 19980813
Title: Comparative pharmacology of human adenosine receptor subtypes - characterization of stably transfected receptors in CHO cells.
Journal: Naunyn-Schmiedeberg's archives of pharmacology 19980101
Title: Pharmacological characterization of novel A3 adenosine receptor-selective antagonists.
Journal: Neuropharmacology 19970901
Title: Derivatives of the triazoloquinazoline adenosine antagonist (CGS15943) are selective for the human A3 receptor subtype.
Journal: Journal of medicinal chemistry 19961011
Title: Shearman LP, et al. 25I4-aminobenzyl-5'-N-methylcarboxamidoadenosine (125I)AB-MECA) labels multiple adenosine receptorsubtypes in rat brain. Brain Res. 1997 Jan 16;745(1-2):10-20.
